BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stafylidou M, Paschos P, Katsoula A, Malandris K, Ioakim K, Bekiari E, Haidich AB, Akriviadis E, Tsapas A. Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2019;17:1744-1755.e11. [PMID: 31077823 DOI: 10.1016/j.cgh.2019.04.062] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Peltekian KM. For fatty liver diseases, it is time to utilize non-invasive fibrosis tests to predict liver related events rather than just histological stages of hepatic fibrosis! Ann Hepatol 2020;19:583-4. [PMID: 32853777 DOI: 10.1016/j.aohep.2020.07.011] [Reference Citation Analysis]
2 Yan Y, Xing X, Lu Q, Wang X, Luo X, Yang L. Two-Dimensional Shear Wave Elastography for Sparing Endoscopy Screening in Patients with HBV-Related Compensated Advanced Chronic Liver Disease. Expert Rev Gastroenterol Hepatol 2021. [PMID: 34939906 DOI: 10.1080/17474124.2022.2020644] [Reference Citation Analysis]
3 Anstee QM, Castera L, Loomba R. Impact of non-invasive biomarkers on hepatology practice: Past, present and future. J Hepatol 2022;76:1362-78. [PMID: 35589256 DOI: 10.1016/j.jhep.2022.03.026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang H, Chen J. Reply to: "Prospective validation of Baveno VI criteria in virally supressed HBV cirrhosis - more evidence is needed". J Hepatol 2021;74:759-60. [PMID: 33353742 DOI: 10.1016/j.jhep.2020.12.002] [Reference Citation Analysis]
5 Dajti E, Colecchia A, Brandi N, Golfieri R, Renzulli M. Reply to: Triple-phase CT scan for disease progression prediction in cirrhosis: A valid repurpose? Eur J Radiol 2022;146:110076. [PMID: 34883410 DOI: 10.1016/j.ejrad.2021.110076] [Reference Citation Analysis]
6 Bangaru S, Benhammou JN, Tabibian JH. Noninvasive scores for the prediction of esophageal varices and risk stratification in patients with cirrhosis. World J Hepatol 2020; 12(11): 908-918 [PMID: 33312418 DOI: 10.4254/wjh.v12.i11.908] [Reference Citation Analysis]
7 Dajti E, Marasco G, Ravaioli F, Alemanni LV, Rossini B, Colecchia L, Vestito A, Festi D, Colecchia A. The role of liver and spleen elastography in advanced chronic liver disease. Minerva Gastroenterol (Torino) 2021;67:151-63. [PMID: 34027932 DOI: 10.23736/S2724-5985.20.02793-2] [Reference Citation Analysis]
8 Nababan SHH, Kalista KF, Jasirwan CO, Kurniawan J, Lesmana CRA, Sulaiman AS, Hasan I, Gani RA. Mac-2 Binding Protein Glycosylation Isomer for Screening High-Risk Esophageal Varices in Liver Cirrhotic Patient. Livers 2021;1:60-7. [DOI: 10.3390/livers1020006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Isfordink CJ, Maan R, de Man RA, van Erpecum KJ, van der Meer AJ. Should we continue surveillance for hepatocellular carcinoma and gastroesophageal varices in patients with cirrhosis and cured HCV infection? Eur J Intern Med 2021:S0953-6205(21)00296-X. [PMID: 34563447 DOI: 10.1016/j.ejim.2021.08.023] [Reference Citation Analysis]
10 Zhou H, Hu H, Tian M, Chu J, Tian C, Yang Y, Lin S. Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk Varices. Gastroenterol Res Pract 2020;2020:4217512. [PMID: 33376483 DOI: 10.1155/2020/4217512] [Reference Citation Analysis]
11 Kim NJ, Su F, Biggins SW. CON: Noninvasive Modalities Are Preferred to Screen for the Diagnosis of Esophageal and Gastric Varices When the Diagnosis of Cirrhosis Is Made. Clin Liver Dis (Hoboken) 2020;16:48-52. [PMID: 32922749 DOI: 10.1002/cld.952] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Siau K, Hayee B, Gayam S. Endoscopy's Current Carbon Footprint. Techniques and Innovations in Gastrointestinal Endoscopy 2021;23:344-52. [DOI: 10.1016/j.tige.2021.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Agarwal S, Sharma S, Jindal A, Singh S, Jagdish R, Gunjan D, Sarin SK, Saraya A. Application of Noninvasive Tools to Decide the Need for Beta-Blockers for Variceal Bleeding Prophylaxis in Compensated Advanced Liver Disease: A Decision Curve Analysis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.09.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sharma S, Agarwal S. Prospective validation of Baveno VI criteria in virally supressed HBV cirrhosis - more evidence is needed. J Hepatol 2021;74:758-9. [PMID: 33353741 DOI: 10.1016/j.jhep.2020.10.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Wang B, Zhou J, Wu X, Sun Y, Li L, Li P, Li M, Jiang W, Xu M, Feng B, Xu X, Cheng J, Xie W, Han T, Wang X, Li H, Piao H, Wu S, Shi Y, Chen S, Kong Y, Ma H, Ou X, Jia J, You H. Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSM. Liver Int 2021;41:369-77. [PMID: 33277803 DOI: 10.1111/liv.14752] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Wong YJ, Kew GS, Tan PS, Chen Z, Putera M, Yip WA, Ang TL, Fock KM, Lee GH, Hsiang J, Huang DQ, Kwek A, Muthiah MD, Kumar R, Tan M, Tan J, Thurairajah PH, Teo EK, Tai BC, Lim SG. Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study. Clin Res Hepatol Gastroenterol 2021;45:101598. [PMID: 33780835 DOI: 10.1016/j.clinre.2020.101598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Richardson E, Arastu S, Halegoua-DeMarzio D. PRO: Esophagogastroduodenoscopy Is the Preferred Modality to Screen for the Diagnosis of Esophageal and Gastric Varices When the Diagnosis of Cirrhosis Is Made. Clin Liver Dis (Hoboken) 2020;16:43-7. [PMID: 32922748 DOI: 10.1002/cld.951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kotwal V, Mbachi C, Wang Y, Attar B, Randhawa T, Flores E, Robles J, Rosenstengle C, Demetria M, Adeyemi O, Huhn G, Murali AR. A Novel Score to Predict Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease. Dig Dis Sci 2021;66:2084-91. [PMID: 32648078 DOI: 10.1007/s10620-020-06456-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Zhou H, Long J, Hu H, Tian CY, Lin SD. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria. World J Gastroenterol 2019; 25(35): 5323-5333 [PMID: 31558876 DOI: 10.3748/wjg.v25.i35.5323] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
20 Gkiouras K, Grammatikopoulou MG, Theodoridis X, Pagkalidou E, Chatzikyriakou E, Apostolidou AG, Rigopoulou EI, Sakkas LI, Bogdanos DP. Diagnostic and clinical significance of antigen-specific pancreatic antibodies in inflammatory bowel diseases: A meta-analysis. World J Gastroenterol 2020; 26(2): 246-265 [PMID: 31988587 DOI: 10.3748/wjg.v26.i2.246] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Asesio N, Pollo-Flores P, Caliez O, Munteanu M, Ngo A, Ngo Y, Poynard T, Thabut D, Rudler M. Baveno VI criteria as a prognostic factor for clinical complications in patients with compensated cirrhosis. Dig Liver Dis 2021:S1590-8658(21)00773-8. [PMID: 34583904 DOI: 10.1016/j.dld.2021.09.004] [Reference Citation Analysis]
22 Zhang X, Wong GL, Wong VW. Application of transient elastography in nonalcoholic fatty liver disease. Clin Mol Hepatol 2020;26:128-41. [PMID: 31696690 DOI: 10.3350/cmh.2019.0001n] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
23 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu., Clinical Practice Guideline Panel., Chair:., EASL Governing Board representative:., Panel members:. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol 2021;75:659-89. [PMID: 34166721 DOI: 10.1016/j.jhep.2021.05.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
24 Shin WR, Park DY, Kim JH, Lee JP, Thai NQ, Oh IH, Sekhon SS, Choi W, Kim SY, Cho BK, Kim SC, Min J, Ahn JY, Kim YH. Structure based innovative approach to analyze aptaprobe-GPC3 complexes in hepatocellular carcinoma. J Nanobiotechnology 2022;20:204. [PMID: 35477501 DOI: 10.1186/s12951-022-01391-z] [Reference Citation Analysis]
25 Majumdar A, Tsochatzis EA. Curve Your Enthusiasm: The Decision to Use Expanded or Original Baveno VI Criteria to Exclude High-Risk Varices. Clinical Gastroenterology and Hepatology 2020;18:1243-4. [DOI: 10.1016/j.cgh.2019.09.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
26 Gaete MI, Díaz LA, Arenas A, González K, Cattaneo M, Fuster F, Henríquez R, Soza A, Arrese M, Barrera F, Arab JP, Benítez C. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort. Liver Int 2020;40:1427-34. [PMID: 31916360 DOI: 10.1111/liv.14373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
27 Nahon P, Ganne-Carrié N. Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication. JHEP Rep 2019;1:480-9. [PMID: 32039400 DOI: 10.1016/j.jhepr.2019.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
28 Ferraioli G. Beyond the AJR: "Two-Dimensional Shear Wave Elastography Predicts Survival in Advanced Chronic Liver Disease". AJR Am J Roentgenol 2021;217:1012. [PMID: 33728973 DOI: 10.2214/AJR.21.25821] [Reference Citation Analysis]
29 Dajti E, Alemanni LV, Marasco G, Montagnani M, Azzaroli F. Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? Hepat Med 2021;13:25-36. [PMID: 33776492 DOI: 10.2147/HMER.S278077] [Reference Citation Analysis]
30 Wang H, Wen B, Chang X, Wu Q, Wen W, Zhou F, Guo Y, Ji Y, Gu Y, Lai Q, He Q, Li J, Chen J, Hou J. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis. Journal of Hepatology 2021;74:584-92. [DOI: 10.1016/j.jhep.2020.09.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
31 Calès P, Ravaioli F, Berger A, Farcau O, Festi D, Stefanescu H, Vitellius C, Nahon P, Bureau C, Ganne-carriè N, Berzigotti A, de Ledinghen V, Petta S. Comparison of screening strategies with two new tests to score and diagnose varices needing treatment. Clinics and Research in Hepatology and Gastroenterology 2022. [DOI: 10.1016/j.clinre.2022.101925] [Reference Citation Analysis]
32 Piedade J, Pereira G, Guimarães L, Duarte J, Victor L, Baldin C, Inacio C, Santos R, Chaves Ú, Nunes EP, Grinsztejn B, Veloso VG, Fernandes F, Perazzo H. Liver stiffness regression after sustained virological response by direct-acting antivirals reduces the risk of outcomes. Sci Rep 2021;11:11681. [PMID: 34083617 DOI: 10.1038/s41598-021-91099-1] [Reference Citation Analysis]
33 Chang JPE, Wong YJ, Yang WL, Lim KBL, Tan PS, Ho GH, Yip BCH, Li JW, Chong CH, Ong DEH, Chua TS, Vu CKF, Gwee KA, Ang TL, Tan CK. Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic. Singapore Med J 2020;61:619-23. [PMID: 32349198 DOI: 10.11622/smedj.2020069] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Hu Y, Wen Z. Validation and comparison of non-invasive prediction models based on liver stiffness measurement to identify patients who could avoid gastroscopy. Sci Rep 2021;11:150. [PMID: 33420233 DOI: 10.1038/s41598-020-80136-0] [Reference Citation Analysis]
35 Tamaki N, Kurosaki M, Higuchi M, Kirino S, Inada K, Yamashita K, Sekiguchi S, Hayakawa Y, Osawa L, Takaura K, Maeyashiki C, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Izumi N. Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis. Hepatol Res 2020;50:996-9. [PMID: 32515534 DOI: 10.1111/hepr.13533] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Ryder SD. Commentary: elastography as a predictor of portal hypertension. Aliment Pharmacol Ther 2020;51:204-5. [PMID: 31850553 DOI: 10.1111/apt.15545] [Reference Citation Analysis]
37 Agarwal A, Pathak P, Gupta S, Kumar R, Shalimar. Baveno criteria perform better than expanded Baveno and Rete Sicilia Selezione Terapia-Hepatitis C virus criteria for predicting varices needing treatment. Indian J Gastroenterol 2021. [PMID: 33991311 DOI: 10.1007/s12664-020-01141-9] [Reference Citation Analysis]
38 Liu Y, Liu C, Li J, Kim TH, Enomoto H, Qi X. Risk stratification of decompensation using liver stiffness and platelet counts in compensated advanced chronic liver disease (CHESS2102). J Hepatol 2021:S0168-8278(21)02112-7. [PMID: 34662676 DOI: 10.1016/j.jhep.2021.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Sharma S, Agarwal S, Gunjan D, Kaushal K, Anand A, Saraya A. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort. Am J Gastroenterol 2020;115:1650-6. [PMID: 32516202 DOI: 10.14309/ajg.0000000000000722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Petrisor A, Stanescu AMA, Papacocea IR, Panaitescu E, Peagu R, Moldoveanu AC, Fierbinteanu-Braticevici C. Non-invasive laboratory, imaging and elastography markers in predicting varices with high risk of bleeding in cirrhotic patients. Rom J Intern Med 2021;59:194-200. [PMID: 33544557 DOI: 10.2478/rjim-2021-0001] [Reference Citation Analysis]
41 Krag A, Roskams T, Pinzani M, Mueller S. Diagnostic challenges in patients with alcohol-related liver disease. Z Gastroenterol 2022;60:45-57. [PMID: 35042253 DOI: 10.1055/a-1713-4372] [Reference Citation Analysis]
42 Papatheodoridi M, Hiriart JB, Lupsor-Platon M, Bronte F, Boursier J, Elshaarawy O, Marra F, Thiele M, Markakis G, Payance A, Brodkin E, Castera L, Papatheodoridis G, Krag A, Arena U, Mueller S, Cales P, Calvaruso V, de Ledinghen V, Pinzani M, Tsochatzis EA. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease. J Hepatol 2021;74:1109-16. [PMID: 33307138 DOI: 10.1016/j.jhep.2020.11.050] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]